Baidu-(NASDAQ-BIDU), a Chinese language internet search provider, is recently up $4.00 to $324 in pre-open trading. The company will report earnings on 10/25. Smith Barney has a $250 price target. November option implied volatility of 89 is above its 26-week average of 56 according to Track Data, suggesting larger price fluctuations.
Vertex Pharma-(NASDAQ-VRTX), is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. The company sold off on 10/18/07 after promising trial data from Schering Plough's-(NYSE-SGP) Hepatitis C drug boceprevir was seen as a threat to VRTX's Telaprevir. Option volume was heavy on 54,154 contracts. November option implied volatility of 75 is above its 26-week average of 48 according to Track Data, suggesting larger price fluctuations.
Daily options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.
America's 10 Highest-Paid CEOs of 2011 (and How They Earned It)
The Richest Woman in the World: How Gina Rinehart Earns her Billions

